SciELO - Scientific Electronic Library Online

 
vol.46 issue2Peer teaching, a didactic strategy for learning basic electrocardiographyPrimary orbital leiomyosarcoma author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Acta Medica Colombiana

Print version ISSN 0120-2448

Acta Med Colomb vol.46 no.2 Bogotá Jan./June 2021  Epub Nov 24, 2021

https://doi.org/10.36104/amc.2021.1947 

Cases presentation

Facial diplegia as a manifestation of neuroleptospirosis

Jenny Patricia Muñoz-Lomboa  * 

Diana Carolina Quintero-Gonzálezb 

José Mauricio Cárdenas-Prietoc 

María Eugenia Casanova-Valderramad 

a Internista, Magister en Epidemiología, Universidad Libre seccional Cali, Clínica Nuestra Señora de los Remedios; Cali (Colombia).

b Internista, Magister en Epide miología, Universidad Libre Seccional Cali, Clínica Nuestra Señora de los Remedios; Cali (Colombia).

c Internista, Universidad Libre Seccional Cali, Gesencro Buga; Cali (Colombia).

d Internista y Neurólogo Clínico. Directora del programa de Medicina Interna Universidad Libre Cali, Grupo Interinstitucional de Medicina Interna (GIMI 1), Dime Clínica Neurocardiovascular. Cali (Colombia).


Abstract

This case series describes the clinical and paraclinical findings in two young men with bilateral peripheral facial palsy or facial diplegia during the convalescent period of leptospirosis, who recovered neurologically without sequelae. This highlights the role of spirochetes in the development of an atypical and rare variant of Guillain-Barré syndrome. (Acta Med Colomb 2021; 46. DOI:https://doi.org/10.36104/amc.2021.1947).

Key words: febrile syndrome; leptospirosis; neurological manifesta tions; facial diplegia; Guillain-Barre syndrome; Colombia

Resumen

Esta serie de caso describe los hallazgos clínicos y paraclínicos observados en dos hombres jóvenes, con parálisis facial periférica bilateral o diplejía facial durante la fase de convalecencia de la leptospirosis, con recuperación neurológica sin secuela; resaltando así, el papel de la espiroqueta en el desarrollo de una variante atípica y poco frecuente del síndrome de Guillain-Barré. (Acta Med Colomb 2021; 46. DOI:https://doi.org/10.36104/amc.2021.1947).

Palabras clave: síndrome febril; leptospirosis; manifestaciones neurológicas; diplejía facial; síndrome de Guillain-Barré; Colombia

Introduction

Bilateral peripheral facial paralysis, or facial diplegia (FD) is a rare neurological manifestation in which each facial nerve is affected simultaneously or within 30 days of each other, accounting for less than 2% of facial pa ralysis cases, with an estimated global incidence of one case per five million population. The most common cause is Guillain-Barré syndrome (GBS), or acute-onset poly-neuroradiculopathy 1, in which facial paralysis occurs in 24 to 60%, in most cases bilaterally. Isolated FD with no or slight involvement of the extremities, is an atypical and rare variant of GBS 2,3. Several types of infection have been associated with GBS, mainly respiratory and gastrointestinal in 70% of cases. The association with lep tospirosis, one of the most widely disseminated zoonoses worldwide (caused by a spirochete from the order Spirochaetales, family Leptospiraceae, and genus Leptospira), has been recorded less frequently 4-7. In most cases, this infection has a biphasic clinical presentation which begins with a septicemic phase, followed by immune signs with a broad clinical spectrum ranging from febrile syndrome with mild constitutional symptoms to severe disease with multiple organ failure 8. It is drawn to certain organs such as the liver, kidneys, heart and skeletal muscle, but also shows neurological signs in 12-40%, such as aseptic meningoencephalitis, cerebrovascular accidents, mono or polyneuritis, cranial nerve paralysis, inflammatory myelopathy, radiculopathy, and the previously mentioned GBS 9,10. The goal of this article is to describe the be havior of two unusual cases of patients with leptospirosis who developed bilateral facial paralysis in the course of their illnesses, as an atypical variant of GBS, given the diagnostic challenge for clinicians posed by this disease.

Clinical cases

Case 1

A 27-year-old male, with no relevant medical history, was seen in the emergency room due to a nine-day history of unquantified fevers, chills, headache, abdominal pain and myalgia, and subsequently developed right peripheral facial palsy, followed by contralateral involvement on the next day, associated with upper extremity paresthesias. On physical exam, he had normal vital signs, with no higher mental function problems, peripheral facial biparesis with out involvement of other cranial nerves, 5/5 strength in all extremities, normal myotendinous reflexes and bilateral flexor plantar reflexes. A simple tomography of the head on admission was reported to be within normal limits, the complete blood count showed leukocytosis (12,800 cells/mm3) without neutrophilia, kidney and liver function were normal, and serology for Leptospira was IgM positive and IgG negative. He was therefore diagnosed with leptospirosis, beginning treatment with 1 gram of intravenous ceftriaxone every 12 hours for seven days. Due to persistent neurological findings, simple magnetic resonance imaging of the brain, with contrast, was performed, which was normal, while the cerebrospinal fluid (CSF) showed albuminocytological dissociation (Table 1, Case 1), suggesting the atypical facial diplegia variant of GBS. Electromyography and conduction velocity tests of each facial nerve supported the diagnosis, showing bilateral demyelinating neuropathy with signs of reinnervation. The patient underwent physical rehabilitation and speech therapy, with gradual recovery and no swallow ing or respiratory difficulties, or weakness in his extremities.

Table 1 Lumbar puncture. 

Case 2

A 36-year-old male international bus driver, with no relevant medical history, was seen in the emergency room due to five days of 38.8°C fever, chills, myalgias, arthralgias, generalized colicky abdominal pain of variable intensity and self-limited epistaxis. On physical exam, he had generalized mucocutaneous jaundice, mild dehydration, epigastric and right upper quadrant pain on palpation, with hepatosplenomegaly confirmed by a total abdominal ultrasound. Blood chemistries showed hemoconcentration (hemoglobin/hematocrit ratio = 42.7% / 12.6 g/dL = 3.38), thrombocytopenia (73,000/mm3), direct hyperbilirubinemia (total 5.2 mg/dL, direct 3.37 mg/dL), elevated transaminases (ALT 165 U/L, AST 150 U/L mg/dL), alkaline phosphatase (237 IU/I) and lactate dehydrogenase (1,098 IU/I), as well as microscopic eumorphic hematuria (10-15/field) with proteinuria (2+). A 24-hour follow up showed leukocytosis with neutrophilia (WBC 12,200 cells/mm3, 80% neutrophils), decreased plate lets (35,000 mm3), elevated CRP (44 mg/dL) and AKIN I acute kidney injury AKIN I (Cr 1.7 mg/dL). An infectious disease panel was ordered, which was negative (serology for Leptospira IgM and IgG, dengue, hepatitis A, B and C, HIV, syphilis, malaria and bacteremia). However, due to his signs and symptoms and paraclinical exams, a tentative diagnosis of Weil syndrome was made, beginning empirical treatment with 1 gram of intravenous ceftriaxone every 12 hours along with fluid resuscitation, and ordering a microscopic agglu tination test for Leptospira (MAT), which confirmed the diagnosis, yielding a positive result for serogroup Australis 1:200 and serogroup Cynopteri 1:400. On the tenth day after the onset of symptoms he developed left peripheral facial palsy with contralateral involvement 24 hours later (facial diplegia), with no other relevant findings on physical exam. A simple head tomography was normal, while the CSF showed albuminocytological dissociation (Table 1, Case 2), suggesting an FD variant of grade 1 Barré Hughes GBS, without progression of the neurological deficit, and thus immunoglobulin or plasmapheresis treatment was not begun. The patient was discharged with rehabilitation and glucocorticoids, as well as follow up with clinical neurology. The FD gradually resolved after three weeks of treatment.

Discussion

We present two cases of patients with leptospirosis in different clinical scenarios, the first with classical leptospi rosis and the second with Weil syndrome, who during the convalescent phase developed peripheral facial biparesis without extremity involvement, as a rare neurological complication of an atypical variant of GBS. This immune-mediated polyneuroradiculopathy is considered to be the most common cause of acute flaccid paralysis worldwide, after the eradication of poliomyelitis 11. Its most common forms are acute inflammatory demyelinating polyneuropathy (AIDP), acute motor axonal neuropathy (AMAN), and acute motor and sensory axonal neuropathy (AMSAN). However, there are atypical variants such as Miller Fisher syndrome (MFS), Bickerstaff encephalitis, the pharyngeal-cervical-brachial (PCB) variant, sixth cranial nerve palsy and FD, which make it difficult to recognize the disease and entail a diagnostic challenge 12. A prospective study of 250 pa tients with GBS found that MFS (5%) and the PCB variant (3%) are the most frequent subtypes, while isolated FD has been reported in 1% of patients 13.

Various viral (cytomegalovirus, Epstein-Barr, influenza A, enterovirus, Zika) and bacterial (Mycoplasma pneu moniae, Haemophilus influenzae, Campylobacter jejuni) infectious agents have been associated with the induction of both humoral and cellular immune responses to create IgG1 and IgG2 antibodies against the axons and myelin, due to molecular mimicry between the oligosaccharides of the infectious organisms and the gangliosides of the neuronal membrane (GM1-GD1a) 14. However, in leptospirosis, the pathophysiology of neurological involvement is still unknown. Some hypotheses propose the presence of immune mechanisms as an explanation for this disease's polymorphic clinical manifestations, including systemic vasculitides with activation of circulating immune complexes which develop 6-15 days after symptom onset 15,16. Another hypothesis is a cross reaction against the myelin sheath of the peripheral nerves 17 caused by globally distributed bacterial zoonoses. Human leptospirosis results from contact with water, soil or foods that have been contaminated with the urine of rats, dogs, pigs or other infected animals. Motile leptospires penetrate broken skin or mucous membranes and cause an acute and systemic illness characterized by a sudden onset of fever, myalgias, intense headaches and conjunctival hemorrhages. The clinical manifestations of the disease are not pathognomonic; therefore, leptospirosis has often been mistakenly diagnosed. Most human cases are mild and unjaundiced; however, 5 to 30% of jaundiced cases may be fatal, due to hemorrhagic complications, aseptic meningitis and kidney failure (Weil syndrome). Wallerian degeneration and perivascular and perineural inflammatory infiltrates de scribed on neuromuscular biopsies of leptospirosis patients validate the association of GBS as a complication of this spirochete infection 17,18.

An association with GBS was found in a literature re view of the last 20 years, in which only eight case reports were found of associated facial paralysis, including three bilateral forms of the disease with comparable neurologi cal involvement and duration to the cases described in this report 19-22. There is no available literature to date on leptospirosis cases associated with the atypical FD variant of GBS, possibly due to a lack of studies on this condition.

The diagnosis of GBS can be based on Wakerley et al.'s modified criteria, in which certain clinical characteristics, including the history of infectious symptoms, presence of bilateral facial weakness, distal paresthesias, decreased or absent deep tendon reflexes and a monophonic disease course with a 12-hour to four-week interval between the onset of the neurological deficit and its nadir, strongly sug gest the FD variant of GBS 23.

There are currently no serum, urine or CSF markers to confirm the disease. However, albuminocytological disso ciation (a normal cell count with elevated proteins) in the CSF is a finding which points to a GBS diagnosis 24. In a study of CSF samples from 474 patients with GBS, the sensitivity of albuminocytological dissociation was found to depend on the time at which the sample was taken, being positive in 49% on the first day of the disease and increas ing to up to 88% after the second week 25. Pleiocytosis (more than five leukocytes in the CSF) is unusual in GBS, but approximately 15% of patients may have a leukocyte count ranging from 5 to 50 cells per high power field, as seen in the second case presented 26.

Conclusion

Leptospirosis is a reemergent zoonosis in the world, and the second cause of febrile syndrome in Colombia. Although kidney, liver and lung involvement are more frequent, neurological complications may develop. Therefore, if facial diplegia develops, the clinician should test the CSF for albuminocytological dissociation which would allow the diagnosis of GBS with this atypical and rare variant of the disease.

References

1. JR K. Bilateral seventh nerve palsy: analysis of 43 cases and review of the literature. Neurology. 1994;44(7):1198-202. [ Links ]

2. Varol S, Ozdemir HH, Akil E, Arslan D, Aluclu MU, Demir CF, et al. Facial diplegia: etiology, clinical manifestations, and diagnostic evaluation. Arq Neuropsiquiatr. 2015;73(12):998-1001. [ Links ]

3. Lehmann HC, MacHt S, Jander S, Hartung HP, Methner A. Guillain-Barré syndrome variant with prominent facial diplegia, limb paresthesia, and brisk reflexes. J Neurol. 2012;259(2):370-1. [ Links ]

4. Torres-Castro M, Hernández-Betancourt S, Agudelo-Flórez P, Arroyave-Sierra E, Zavala-Castro J, Puerto FI. Artículos de revisión Revisión actual de la epidemiología de la leptospirosis Current review of the epidemiology of leptospirosis. Vol. 54, Rev Med Inst Mex Seguro Soc. 2016. [ Links ]

5. Adler B, de la Peña Moctezuma A. Leptospira and leptospirosis. Vet Microbiol. 2010;140(3-4):287-96. [ Links ]

6. Kobawaka Gamage KK, Fernando H. Leptospirosis complicated with Guillain Barre syndrome, papillitis and thrombotic thrombocytopenic Purpura; A case report. BMC Infect Dis. 2018;18(1):1-4. [ Links ]

7. Dev N, Kumar R, Kumar D. Guillain-Barre syndrome: a rare complication of leptospirosis and scrub typhus co-infection. Trop Doct. 2019;3-4. [ Links ]

8. El Bouazzaoui A, Houari N, Arika A, Belhoucine I, Boukatta B, Sbai H, et al. Facial palsy associated with leptospirosis. Eur Ann Otorhinolaryngol Head Neck Dis. 2011 Nov;128(5):275-7. [ Links ]

9. Levett PN. Leptospirosis: A forgotten zoonosis? Vol. 4, Clinical and Applied Immunology Reviews. Elsevier; 2004. p. 435-48. [ Links ]

10. Gaillard T, Martinaud C, Faivre A, Souraud JB, Maslin J, Alla P, et al. Moyens biologiques et stratégie diagnostique de la leptospirose neuroméningée. À propos d'un cas. Rev Med Interne. 2009 Apr;30(4):361-4. [ Links ]

11. Lehmann HC, Macht S, Jander S, Hartung HP MA. Guillain-Barré syndrome variant with prominent facial diplegia, limb paresthesia, and brisk reflexes. J Neurol. 2012;259(2):370-1. [ Links ]

12. Mazen M. Dimachkie, M.D., Richard J. Barohn M, Dimachkie, Mazen M . et al . Guillain-Barré Syndrome and Variants Mazen. Neurol Clin. 2014;31(2):491-510. [ Links ]

13. When is facial diplegia regarded as a variant of Guillain-Barré syndrome? J Peripher Nerv Syst. 2015;20(1):32-6. [ Links ]

14. Eelco F.M. Wijdicks CJK. Guillain-Barré Syndrome. Mayo Clin Proc. 2017;92(3):467-79. [ Links ]

15. Thukral A, Khan I, Tripathi K. Slurred speech and spirochaetes. Lancet. 2009;373(9667):978. [ Links ]

16. de Souza AL, Sztajnbok J, Spichler A, Carvalho SM, de Oliveira ACP, Seguro AC. Peripheral nerve palsy in a case of leptospirosis. Trans R Soc Trop Med Hyg. 2006 Jul;100(7):701-3. [ Links ]

17. Carrada T. Leptospirosis humana. Historia natural, diagnóstico y tratamiento Leptospirosis. Rev Mex Patol Clin. 2005;52(4):246-56. [ Links ]

18. P. Azouvi, T. Hostachy, M. Desi et al. Polyneuropathie axonale aigue et réversible dans les suites d'une leptospirose. Rev Neurol. 1989;145:805-7. [ Links ]

19. Maldonado F, Portier H, Kisterman JP. Bilateral facial palsy in a case of leptospirosis. Scand J Infect Dis. 2004;36(5):386-8. [ Links ]

20. Andosilla LM, Brun MF, Miranda Col CC, Alberto Lora Andosilla M, Macia Brun F, Arturo Cassiani Miranda C, et al. Parálisis facial periférica bilateral como presentación inicial del síndrome de Guillain-Barré: informe de un caso Bilateral facial nerve paralysis as initial manifestation of guillain-barré syndrome: a case report Caso clínico ActA NeurológicA colombiANA [Internet]. Vol. 31, Acta Neurol Colomb. 2015 [cited 2019 Aug 4]. Available from: Available from: http://www.scielo.org.co/pdf/anco/v31n4/v31n4a13.pdfLinks ]

21. Costa E, Sacramento E, Lopes AA, Bina JC. Facial nerve palsy associated with leptospirosis. Rev Soc Bras Med Trop [Internet]. 2001 Apr [cited 2019 Sep 9];34(2):219-20. Available from: Available from: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822001000200011&lng=en&tlng=enLinks ]

22. Midon A, Corrêa FB, Maia RD, Sampaio AG, Rosa Júnior M. Bilateral facial paralysis associated with leptospirosis. Vol. 51, Radiologia Brasileira. Colegio Brasileiro de Radiologia; 2018. p. 335. [ Links ]

23. Wakerley BR, Uncini A, Yuki N. Guillain-Barré and miller fisher syndromes -New diagnostic classification. Nat Rev Neurol. 2014;10(9):537-44. [ Links ]

24. Wong AHY, Umapathi T, Nishimoto Y, Wang YZ, Chan YC, Yuki N. Cytoalbuminologic dissociation in Asian patients with Guillain-Barré and Miller Fisher syndromes. J Peripher Nerv Syst. 2015;20(1):47-51. [ Links ]

25. Fokke C, Van Den Berg B, Drenthen J, Walgaard C, Van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137(1):33-43. [ Links ]

26. Esposito S, Longo MR. Guillain-Barré syndrome. Autoimmun Rev. 2017;16(1):96-101. [ Links ]

Received: July 13, 2020; Accepted: December 22, 2020

*Correspondencia: Dr. Jenny Patricia Muñoz-Lombo. Cali (Colombia). E-mail: ideasenproceso@hotmail.com

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License